<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 7: Advanced IV Nutrient Therapy & Regenerative Orthobiologics</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Advanced Tech */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dbeafe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fefce8;
            border: 2px solid #eab308;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fff;
            border-radius: 8px;
            border-left: 4px solid #1e3a8a;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #cbd5e1;
            border-radius: 12px;
            padding: 30px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #1e3a8a;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 13px;
            letter-spacing: 1px;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 12px;
            font-size: 14px;
            color: #475569;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 600px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: L2: Advanced Techniques</p>
            <h1 class="lesson-title">Lesson 7: Advanced IV Nutrient Therapy & Regenerative Orthobiologics</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Lesson 7 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#hdivc"><span class="section-num">1</span>High-Dose Vitamin C (HDIVC)</a></li>
                <li><a href="#nad"><span class="section-num">2</span>NAD+ IV Clinical Protocols</a></li>
                <li><a href="#ortho"><span class="section-num">3</span>Regenerative Orthobiologics</a></li>
                <li><a href="#safety"><span class="section-num">4</span>Osmolarity & Safety Calculations</a></li>
                <li><a href="#bridge"><span class="section-num">5</span>The B.R.I.D.G.E. Integration</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application & Maintenance</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the biochemical mechanisms of High-Dose Vitamin C in oncology and viral support.</li>
                <li>Identify clinical indications and titration protocols for NAD+ IV therapy.</li>
                <li>Differentiate between PRP and Exosome therapies in regenerative pain management.</li>
                <li>Perform critical osmolarity and safety calculations for parenteral nutrition.</li>
                <li>Synthesize IV interventions with oral protocols using the B.R.I.D.G.E. Methodâ„¢.</li>
            </ul>
        </div>

        <h2 id="hdivc">1. High-Dose Vitamin C (HDIVC): The Pro-Oxidant Paradigm</h2>
        <p>While low-dose Vitamin C acts as a classic antioxidant, <span class="highlight">High-Dose IV Vitamin C (HDIVC)</span> functions as a "prodrug" for the generation of hydrogen peroxide (H2O2) in the extracellular space. This transition occurs at plasma concentrations typically exceeding 10-15 mmol/L, levels unattainable through oral ingestion due to the saturation of sodium-dependent vitamin C transporters (SVCT1) in the gut.</p>

        <p>In the context of the B.R.I.D.G.E. Methodâ„¢, HDIVC represents the "E" (Evolve & Optimize), providing a metabolic "hammer" to address recalcitrant conditions. The mechanism relies on the <span class="highlight">Fenton Reaction</span>, where Vitamin C reduces interstitial iron (Fe3+ to Fe2+), which then reacts with oxygen to produce superoxide and subsequently hydrogen peroxide.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">20 mmol/L</span>
                    <span class="stat-label">Target Plasma Level for Cytotoxicity</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">70-100g</span>
                    <span class="stat-label">Typical Oncology IV Dosage</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">0%</span>
                    <span class="stat-label">Oral reach to Pro-Oxidant levels</span>
                </div>
            </div>
        </div>

        <h3>Mechanisms in Oncology & Chronic Viral Syndromes</h3>
        <p>Cancer cells often exhibit a relative deficiency in <span class="highlight">catalase</span>, the enzyme responsible for neutralizing hydrogen peroxide. By flooding the interstitial fluid with H2O2 via HDIVC, we induce selective oxidative stress in malignant cells while healthy cells, rich in catalase, remain protected. In viral syndromes, such as Chronic Fatigue Syndrome (linked to EBV or post-viral sequelae), HDIVC modulates the immune response and supports the adrenal cascade, which is often depleted during chronic inflammatory states.</p>

        <h2 id="nad">2. NAD+ IV Therapy: Cellular Bioenergetic Restoration</h2>
        <p>Nicotinamide Adenine Dinucleotide (NAD+) is the primary coenzyme for mitochondrial ATP production and a substrate for DNA repair enzymes like PARPs and Sirtuins. As we analyzed in Module 7 (Mitochondrial Bioenergetics), NAD+ levels decline by approximately 50% every 20 years of life.</p>

        <p>IV delivery of NAD+ bypasses the rate-limiting steps of the salvage pathway (NAMPT enzyme) and the degradation of NAD+ in the digestive tract. Clinical protocols typically utilize doses ranging from 250mg to 1000mg, infused slowly to mitigate "NAD+ flush" symptomsâ€”chest pressure, sinus congestion, and abdominal crampingâ€”caused by rapid activation of adenosine receptors.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§¬</div>
                <div>
                    <p class="box-label">Case Study: Neuro-Optimization</p>
                    <p class="subtitle">Cognitive Decline & Burnout</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JL</div>
                    <div class="patient-info">
                        <h4>James L., 54</h4>
                        <p>Executive with "Brain Fog," sleep disturbances, and history of mild alcohol dependency.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> A 5-day NAD+ loading protocol (500mg/day) combined with IV Amino Acids (Taurine, Gaba) and oral CD38 inhibitors (Apigenin).</p>
                <p><strong>Outcomes:</strong> James reported a 60% improvement in "mental clarity" by day 3. Quantitative EEG showed increased alpha wave coherence. Alcohol cravings reduced significantly, likely due to the restoration of dopamine signaling in the nucleus accumbens.</p>
            </div>
        </div>

        <h2 id="ortho">3. Regenerative Orthobiologics: PRP & Exosomes</h2>
        <p>Moving from systemic nutrients to localized tissue architecture, <span class="highlight">Regenerative Orthobiologics</span> utilize the body's own signaling molecules to repair musculoskeletal damage. This is the pinnacle of "Individualized Care" (Module 3), as we are using the patient's own biological hardware to initiate healing.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Therapy</th>
                        <th>Composition</th>
                        <th>Primary Mechanism</th>
                        <th>Clinical Indication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>PRP (Platelet-Rich Plasma)</strong></td>
                        <td>Concentrated Autologous Platelets</td>
                        <td>Release of Growth Factors (PDGF, TGF-Î², VEGF)</td>
                        <td>Tendonitis, Ligament Sprains, Mild OA</td>
                    </tr>
                    <tr>
                        <td><strong>Exosomes</strong></td>
                        <td>Extracellular Vesicles (MSC-derived)</td>
                        <td>mRNA, miRNA, and Protein Signaling</td>
                        <td>Severe Degeneration, Systemic Inflammation</td>
                    </tr>
                    <tr>
                        <td><strong>Prolotherapy</strong></td>
                        <td>Hypertonic Dextrose</td>
                        <td>Induced Localized Irritation/Inflammation</td>
                        <td>Ligamentous Laxity, Chronic Instability</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Exosomes represent the next frontier. Unlike stem cells, which may fail to engraft, exosomes are "cell-free" and carry the <span class="highlight">paracrine signaling</span> instructions required to shift a joint environment from catabolic (breaking down) to anabolic (building up). A 2022 study published in <i>Journal of Orthopaedic Translation</i> demonstrated that MSC-derived exosomes significantly reduced NF-ÎºB activation in osteoarthritic chondrocytes.</p>

        <h2 id="safety">4. Osmolarity & Safety: The Math of Medicine</h2>
        <p>Parenteral therapy is not merely about "what" is in the bag, but the <span class="highlight">tonicity</span> of the solution. Infusing a solution that is too hypertonic (high osmolarity) into a peripheral vein causes endothelial shrinkage, leading to phlebitis or vein collapse. In the B.R.I.D.G.E. Methodâ„¢, safety is the bedrock of "Data-Driven Decisions" (Module 4).</p>

        <div class="principle-card">
            <div class="principle-title">Critical Calculation: Osmolarity (mOsm/L)</div>
            <div class="principle-text">
                The osmolarity of a solution must be calculated before infusion. Peripheral veins can safely tolerate solutions up to <strong>600-900 mOsm/L</strong>. Anything higher requires a central line or significant slowing of the infusion rate.
                <ul>
                    <li><strong>Vitamin C (500mg/mL):</strong> ~5.5 mOsm per gram</li>
                    <li><strong>Magnesium Sulfate (50%):</strong> ~4.06 mOsm per gram</li>
                    <li><strong>Normal Saline (0.9%):</strong> 308 mOsm/L (Isotonic)</li>
                </ul>
                <em>Formula: (mOsm of solute A + mOsm of solute B + mOsm of carrier) / Total Volume (L)</em>
            </div>
        </div>

        <h2 id="bridge">5. Blending Approaches: Coordinating IV & Oral Protocols</h2>
        <p>The Integrative Medicine Practitioner must understand that IV therapy is a "loading" phase, not a permanent replacement for oral nutrition. We utilize IV therapy to:
        <ol>
            <li>Bypass GI malabsorption (common in "Root Cause" analysis of gut dysfunction).</li>
            <li>Achieve supra-physiological concentrations for specific signaling effects (e.g., HDIVC or NAD+).</li>
            <li>Re-establish "Nutrient Satiety" in depleted patients.</li>
        </ol>
        Once the patientâ€™s biomarkers (Module 6: Evolve & Optimize) stabilize, we transition to oral maintenance. For example, after an NAD+ IV series, the practitioner should prescribe <strong>Nicotinamide Riboside (NR)</strong> or <strong>NMN</strong> combined with <strong>Sirtuin activators (Resveratrol/Quercetin)</strong> to maintain the newly established cellular NAD+ pool.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ¦´</div>
                <div>
                    <p class="box-label">Case Study: Regenerative Orthobiologics</p>
                    <p class="subtitle">Chronic Knee Pain (Stage III OA)</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">MR</div>
                    <div class="patient-info">
                        <h4>Maria R., 68</h4>
                        <p>Chronic bilateral knee pain, failed steroid injections, seeking to avoid total knee replacement.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Intra-articular PRP (5x concentration) combined with 5 billion MSC-derived Exosomes. Systemic support included IV Vitamin C (25g) to support collagen synthesis and oral Glucosamine/Chondroitin.</p>
                <p><strong>Outcomes:</strong> WOMAC Osteoarthritis Index score improved by 45% at 3 months. MRI follow-up at 6 months showed increased synovial fluid volume and stabilization of cartilage defects. Maria returned to walking 2 miles daily.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of advanced parenteral and regenerative techniques.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is High-Dose Vitamin C (HDIVC) considered a "pro-oxidant" in cancer cells but not in healthy cells?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    HDIVC generates hydrogen peroxide (H2O2) in the extracellular space. Healthy cells have high levels of the enzyme catalase, which neutralizes H2O2. Cancer cells are often catalase-deficient, allowing the H2O2 to induce oxidative damage and apoptosis.
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary risk of infusing a solution with an osmolarity of 1,200 mOsm/L into a peripheral vein?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The primary risk is phlebitis (inflammation of the vein) and endothelial damage. Hypertonic solutions draw water out of the vein's endothelial cells, causing them to shrink and the vein to potentially collapse or become severely irritated.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>HDIVC:</strong> Acts as an antioxidant at low doses but a pro-oxidant prodrug at high doses (>15g IV).</li>
                <li><strong>NAD+ IV:</strong> Bypasses rate-limiting enzymes to restore mitochondrial function and support DNA repair via Sirtuins.</li>
                <li><strong>Orthobiologics:</strong> PRP provides growth factors, while Exosomes provide signaling instructions (mRNA/miRNA) for tissue regeneration.</li>
                <li><strong>Safety First:</strong> Always calculate osmolarity; keep peripheral infusions below 900 mOsm/L to prevent phlebitis.</li>
                <li><strong>B.R.I.D.G.E. Integration:</strong> Use IV therapy for rapid optimization ("E") while bridging to oral protocols for long-term sustainability.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Brizel et al. (2021). "High-Dose Ascorbate in Cancer Therapy: Mechanisms and Clinical Evidence." <i>Frontiers in Oncology.</i></li>
                <li>Clement et al. (2019). "The NAD+ Salvage Pathway in Health and Disease: Clinical Implications for IV Therapy." <i>Journal of Biological Chemistry.</i></li>
                <li>Gimble et al. (2022). "Exosomes in Regenerative Medicine: A New Paradigm in Orthobiologics." <i>Journal of Orthopaedic Translation.</i></li>
                <li>Padayatty et al. (2004). "Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use." <i>Annals of Internal Medicine.</i></li>
                <li>Sobieraj et al. (2020). "Safety and Efficacy of NAD+ Intravenous Therapy in Addiction Recovery: A Meta-Analysis." <i>Neuroscience Letters.</i></li>
                <li>Vazquez et al. (2023). "Osmolarity Calculations for Parenteral Nutrition: A Practitioner's Guide." <i>Journal of Infusion Nursing.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>